et al. reported that the incidence of major adverse cardiac events (MACE) in a CR group was significantly lower than that in a non-CR group (used as a control group) of elderly male CVD patients (eleven patients, 30% vs. forty-six patients, 62%, p=0.001) who were followed for up to 3,500 days (3) . However, the rates of all-cause mortality and cardiovascular death in the CR and non-CR groups in their study did not differ to a statistically significant extent. Since the CR program is clearly effective for maintaining the cardiac function, we should not perform a randomized study.
